Introduction
============

Cardiovascular diseases remain the leading cause of death among women in the most developed areas of the world ([@B01]). Studies have demonstrated that menopause can induce metabolic, endothelial and autonomic dysfunctions and increase oxidative stress in women, thus increasing cardiovascular risk ([@B02]-[@B05]). Similarly, rats subjected to ovarian hormone deprivation presented increased blood pressure (BP) and sympathetic tonus and reduced baroreflex sensitivity (BRS) compared to control female rats ([@B06]).

On the other hand, simvastatin treatment reduces both mortality and coronary events in humans, and also prevents and controls atherosclerosis ([@B07], [@B08]). The beneficial pleiotropic effects of simvastatin treatment may be due to the endothelial protection, oxidative stress reduction, sympathetic decrease, and control of inflammatory reactions it seems to offer ([@B09]-[@B12]).

In addition, exercise training has been recognized as a non-pharmacological treatment for cardiovascular disease. A recent systematic review of randomized, controlled trials reported benefits of regular exercise after menopause ([@B13]). Furthermore, previous studies performed in our laboratory have demonstrated that exercise training induced a reduction in body weight, BP and cardiac oxidative stress and an increase in BRS in an experimental model of menopause ([@B06], [@B14], [@B15]).

However, there are few data in the literature concerning the effects of either pharmacological or non-pharmacological approaches on hemodynamic, autonomic or oxidative stress profile changes induced by ovarian hormone deprivation. Also, there are no data on the effects of the association of simvastatin treatment with exercise training, two common approaches used in postmenopausal women in clinical practice.

Therefore, the purpose of the present study was to test the hypothesis that short-term simvastatin treatment (2 weeks) can induce cardiovascular and autonomic improvement and reduce oxidative stress when evaluated by membrane lipoperoxidation. Moreover, we hypothesized that simvastatin treatment can induce additional benefits in physically trained ovariectomized rats.

Material and Methods
====================

Animals and groups
------------------

Experiments were performed on 24 female Wistar rats (215-230 g) from the animal house of the Universidade São Judas Tadeu, São Paulo, Brazil. The rats were given standard laboratory chow and water *ad libitum* and were housed in individual cages in a temperature-controlled room (22°C) with a 12-h dark/light cycle. All rats were treated similarly in terms of daily manipulation. The experimental protocol was approved by the institutional Animal Care and Use Committee of Universidade São Judas Tadeu and the investigation was conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1985). Ovariectomized rats were randomly assigned to the following groups: sedentary (SO, n = 8), sedentary treated with simvastatin (SSO, n = 8), and exercise trained treated with simvastatin (STO, n = 8).

Ovariectomy
-----------

At 10-12 weeks of age, animals were anesthetized (80 mg/kg ketamine and 12 mg/kg xylazine), and a small abdominal incision was made. The ovaries were then located, and a silk thread was tightly tied around the oviduct, including the ovarian blood vessels. The oviduct was sectioned and the ovaries removed. The skin and muscle wall were then sutured with silk thread. After surgery, the animals received an injection of antibiotics (40,000 U/kg penicillin G procaine, *im*) ([@B06], [@B14], [@B16]).

Exercise training
-----------------

Exercise training was performed on a motor treadmill at low-moderate intensity (≈40 to 65% maximal running speed) for 1 h a day, 5 days a week, for 8 weeks, with a gradual increase in speed from 0.3 to 1.2 km/h. All animals were adapted to the procedure (10 min/day, 0.3 km/h) for 1 week before beginning the exercise training protocol. This adaptation period began 24 h after ovariectomy ([@B06], [@B14]). All groups were subjected to a maximal treadmill test, as described in detail in a previous publication ([@B17], [@B18]). The tests were performed three times: 1) at the beginning of the experiment, 2) in the fourth week, and 3) in the eighth week of the training protocol. The purpose was to determine maximal physical capacity and exercise training intensity.

Simvastatin treatment
---------------------

Simvastatin treatment (5 mg kg^-1^·day^-1^) was performed daily by gavage in the last 2 weeks of sedentarism or training. The SO group was submitted to a daily gavage of water. The choice of a simvastatin dose of 5 mg kg^-1^·day^-1^ was based on a pilot study in which we compared the dose of 20 mg kg^-1^·day^-1^ to a dose of 5 mg kg^-1^·day^-1^ in male rats. The results of these experiments showed that the dose of 20 mg kg^-1^·day^-1^ induced further reduction in triglycerides and total cholesterol in treated male rats, which could induce changes in cardiac and autonomic functions, independently of the pleiotropic effects of simvastatin. Considering these results and the fact that the dose of 5 mg/kg did not induce changes in the metabolic parameters evaluated, for the present experiments we chose the simvastatin dose of 5 mg/kg.

Metabolic evaluations
---------------------

Body weight was measured at the beginning and at the end of the protocol. Blood glucose and triglycerides were evaluated after 4 h fasting at the beginning and at the end of the protocol using the Roche GCT Accutrend (Roche, Brazil).

Cardiovascular assessments
--------------------------

After the last training session, 2 catheters filled with 0.06 mL saline were implanted into the carotid artery and jugular vein (PE-10) of anesthetized rats (80 mg/kg ketamine and 12 g/kg xylazine) for direct measurement of BP and for drug administration, respectively. The rats were conscious and allowed to move freely during the hemodynamic experiments. The arterial cannula was connected to a strain-gauge transducer (Blood Pressure XDCR, Kent Scientific, USA), and blood pressure signals were recorded over a 30-min period by a microcomputer equipped with an analog-to-digital converter board (CODAS, 2-kHz sampling frequency; Dataq Instruments, Inc., USA). The recorded data were analyzed on a beat-to-beat basis to quantify changes in mean BP (MBP) and heart rate (HR). Increasing doses of phenylephrine (0.25 to 32.0 µg/kg, *iv*) and sodium nitroprusside (0.05 to 1.6 µg/kg, *iv*) were given as sequential bolus injections (0.1 mL) to produce pressure responses ranging from 5 to 40 mmHg. A 3- to 5-min interval between doses was necessary for blood pressure to return to baseline. Peak increases or decreases in MBP after phenylephrine or sodium nitroprusside injection and the corresponding peak reflex changes in HR were recorded for each dose of the drug. BRS was evaluated by a mean index relating changes in HR to the changes in MBP to allow for separate analysis of gain for reflex bradycardia and reflex tachycardia. The mean index was expressed as bpm/mmHg, as described elsewhere ([@B14], [@B15]).

Vagal and sympathetic effects were studied by injecting methylatropine (3 mg/kg, *iv*) and propranolol (4 mg/kg, *iv*) at a dose of 0.1 mL/100 g body weight. Resting HR was recorded while the rats were in their cages in an unrestrained state, and methylatropine was injected immediately after the recording. Because the HR response to these drugs reaches its peak within 5 min, this time interval was allowed to elapse before the HR measurement was made. On the following day, the sequence of injection was inverted, with propranolol given first. The sympathetic effect was determined as the difference between the basal HR and the lowest HR after propranolol. The vagal effect was obtained by the difference between the maximum HR after methylatropine injection and the basal HR ([@B19]).

Evaluation of membrane lipoperoxidation
---------------------------------------

The animals were killed by decapitation and the heart (ventricles) and liver were immediately removed, rinsed in saline, and trimmed to remove fat tissue and visible connective tissue. These tissues were cut into small pieces, placed in ice-cold buffer, and homogenized in an ultra-Turrax blender with 1 g tissue per 5 mL 150 mM KCl and 20 nM sodium phosphate buffer, pH 7.4. The homogenates were centrifuged at 600 *g* for 10 min at -2°C. Tissue membrane lipoperoxidation was evaluated by chemiluminescence. The chemiluminescence assay was carried out with an LKB Rack Beta liquid scintillation spectrometer 1215 (LKB Producer AB, USA) in the out-of-coincidence mode at room temperature (25° to 27°C). The supernatants were diluted in 140 mM KCl and 20 mM sodium phosphate buffer, pH 7.4, and added to glass tubes, which were placed in scintillation vials; 3 mM tert-butylhydroperoxide was added, and chemiluminescence was determined up to the maximal level of emission ([@B14], [@B20], [@B21]).

Statistical analysis
--------------------

Data are reported as means ± SE. Comparisons between the 3 groups were performed by one-way ANOVA followed by the Student-Newman-Keuls *post hoc* test. Pearson\'s correlation was used to determine association among variables. The level of significance was established at P \< 0.05.

Results
=======

There were no differences in body weight between groups at the beginning of the protocol (SO = 207 ± 2.5 g). At the end of the training period, SSO and STO animals (SSO = 306 ± 5 g; STO = 308 ± 8 g) had a smaller increase in body weight compared to SO animals (323 ± 4 g). No difference in blood metabolic parameters was observed between groups at the beginning of the protocol. After 4 h of fasting, blood glucose (SO = 89 ± 2 mg/dL) and triglycerides (SO = 97 ± 5 mg/dL) did not differ between groups at the end of the protocol.

Maximal physical performance was evaluated by the response to the maximal treadmill test. At the beginning of the experiment, the physical performance was similar for all groups (SO = 2 ± 0.08 km/h). However, the animals submitted to the exercise training protocol (STO = 2.4 ± 0.09 km/h) showed an increase in maximum running speed compared to the SO (2 ± 0.09 km/h) and SSO (1.9 ± 0.07 km/h) groups after 8 weeks of exercise training.

Simvastatin treatment associated or not with exercise training induced reduction in systolic BP (SBP; STO = 120 ± 3 and SSO = 123 ± 2 *vs* SO = 140 ± 2 mmHg; P \< 0.001), diastolic BP (DBP; STO = 82 ± 2 and SSO = 92 ± 2 *vs* SO = 104 ± 2 mmHg; P \< 0.001) and MBP (STO = 99 ± 2 and SSO = 107 ± 2 *vs* SO = 122 ± 1 mmHg; P \< 0.001). The exercise training associated with simvastatin treatment (STO) induced an additional reduction in MBP compared to the animals treated with simvastatin alone (SSO) ([Figure 1A](#f01){ref-type="fig"}). HR was lower in trained rats (STO = 329 ± 6 bpm) when compared to sedentary rats treated or not with simvastatin (SSO = 366 ± 8 and SO = 374 ± 7 bpm) ([Figure 1B](#f01){ref-type="fig"}).

![Mean arterial pressure (MAP; *A*) and heart rate (HR; *B*) of sedentary ovariectomized rats (SO), sedentary ovariectomized rats treated with simvastatin (SSO), and trained ovariectomized rats treated with simvastatin (STO). \*P \< 0.05 *vs* SO group; ^+^P \< 0.05 *vs* SSO group (one-way ANOVA followed by the Student-Newman-Keuls test).](1414-431X-bjmbr-20122111-gf001){#f01}

The tachycardic (SSO = 3.5 ± 0.2 and STO = 3.4 ± 0.2 *vs* SO = 2.7 ± 0.2 bpm/mmHg) and the bradycardic (SSO = -1.6 ± 0.10 and STO = -1.6 ± 0.15 *vs* SO = -1.2 ± 0.1 bpm/mmHg) responses evoked by the baroreflex during BP reductions and increases, respectively, were increased in rats treated with simvastatin, regardless of any association with exercise training, when compared to sedentary ovariectomized rats (SO; [Figure 2A](#f02){ref-type="fig"}).

![Baroreflex sensitivy (BRS) evaluated by bradycardic and tachycardic responses to blood pressure changes (*A*) and autonomic control of heart rate (HR) reflected in vagal and sympathetic effects (*B*) in sedentary ovariectomized rats (SO), sedentary ovariectomized rats treated with simvastatin (SSO) and trained ovariectomized rats treated with simvastatin (STO). \*P \< 0.05 *vs* SO group; ^+^P \< 0.05 *vs* SSO group (one-way ANOVA followed by the Student-Newmann-Keuls test).](1414-431X-bjmbr-20122111-gf002){#f02}

The vagal effect was increased in trained rats (STO = 99 ± 21 bpm) compared to sedentary rats treated or not with simvastatin (SO = 55 ± 5 and SSO = 67 ± 6 bpm). However, the sympathetic effect was decreased in sedentary rats treated with simvastatin (SSO = 28 ± 4 bpm) compared to sedentary rats (SO = 54 ± 6 bpm; [Figure 2B](#f02){ref-type="fig"}).

Oxidative stress evaluated by membrane lipoperoxidation showed a significant reduction in liver homogenates from animals submitted to simvastatin treatment (≈21%) and from animals submitted to exercise training associated with simvastatin treatment (≈57%) compared to the sedentary group (SO). No difference in cardiac lipoperoxidation was observed between the two groups ([Table 1](#t01){ref-type="table"}).

Correlation analysis involving all animals studied demonstrated that cardiac lipoperoxidation was negatively related to the vagal effect (r = -0.7; r^2^ = 0.49; P \< 0.05) and positively correlated to the sympathetic effect (r = 0.7; r^2^ = 0.49; P \< 0.05).

Discussion
==========

Important insights were obtained in the present study. Firstly, although the simvastatin-treated ovariectomized rats, either trained or not, showed unchanged blood triglycerides and glucose levels (after 4 h of fasting), they indeed presented decreased body weight, SBP, DBP, and MBP compared to sedentary ovariectomized rats. Secondly, simvastatin treatment of sedentary or trained ovariectomized rats induced improved bradycardic and tachycardic baroreflex responses compared to sedentary untreated rats, a fact possibly related to a decrease in cardiac sympathetic effect (sedentary group treated with simvastatin) or with an increase in vagal effect on the heart (trained group). Thirdly, simvastatin treatment of ovariectomized animals (SSO and STO groups) induced a reduction in membrane lipoperoxidation of the liver, the target organ for the lipid-regulating effect of this drug. Fourthly and importantly, the BP and liver lipoperoxidation reductions in the simvastatin-treated groups were more pronounced in trained rats and were accompanied by resting bradycardia and improved physical capacity. Finally, the levels of cardiac lipoperoxidation were correlated with the autonomic control of HR, suggesting that improved autonomic cardiac control could be associated with reduced oxidative stress in the heart.

The incidence of cardiovascular disease in women increases sharply after menopause and probably involves changes in BP and its regulation associated with estrogen loss ([@B02]-[@B03]). In the present study, we showed elevated BP values in ovariectomized rats when compared to BP values previously found not only in intact female rats but also in male rats ([@B06], [@B16], [@B21]-[@B23]).In fact, ovariectomized rats showed an increase in BP values, reaching values similar to the ones observed in our experiments ([@B06]). Moreover, some previous studies have not shown a decrease in BP values after simvastatin treatment in male rabbits, rats or humans ([@B09], [@B24]-[@B26]). In the present study, we showed a decrease in BP after simvastatin treatment, corroborating previous data that demonstrated BP reduction after long-term simvastatin treatment ([@B27], [@B28]). Reduction in BP values after training was reported in normotensive postmenopausal women ([@B13], [@B29]).Moreover, previous studies have shown that low- to moderate-intensity exercise training is an efficient nonpharmacological treatment for hypertension ([@B30]-[@B32]). This is the first study to demonstrate that simvastatin treatment in trained rats increases the BP reduction observed in rats only exposed to this pharmacological approach.

The mechanisms involved in BP reduction may be related to changes in cardiac output or peripheral resistance. It is well established that increased oxidative stress plays an important role in endothelial and cardiac dysfunctions, which are involved in the vasomotor and cardiac tonus. It is important to emphasize that an additional BP reduction was observed in STO animals. This change may be associated with the resting bradycardia observed in this group, which could induce a reduction in cardiac output. In fact, some investigators ([@B33]) have reported that exercise training causes a reduction in cardiac output in hypertensive subjects, whereas others ([@B30]) have observed a decrease in total peripheral resistance in humans. The resting bradycardia verified in the trained ovariectomized rats treated with simvastatin can be attributed to the increased cardiac vagal tonus obtained in this group as previously documented in males and ovariectomized females ([@B06], [@B15], [@B19]).

BRS dysfunction has been documented in cardiovascular diseases as an important predictor of mortality and survival ([@B34]). Thus, the identification of the mechanism underlying a depressed BRS, as well as the study of therapies to improve this cardiovascular reflex, have important clinical implications. Davy et al. ([@B35]) have reported that physically active postmenopausal women present higher BRS when compared to age-matched less active women, providing insights into a possible cardioprotective mechanism in physically active postmenopausal women. Pliquett et al. ([@B09]) have also shown baroreflex improvement in rabbits with heart failure after statin treatment without changes in total plasma or high-density cholesterol. In the present study, we demonstrated that simvastatin treatment, associated or not with exercise training in an experimental model of ovarian hormone deprivation, induced an improvement in BRS for both the bradycardic and tachycardic responses evoked by BP rises and falls, respectively.

The improvement in this important cardiovascular reflex could be due to changes in the efferent pathways, since the vagal effect was increased in the trained group and the sympathetic effect was decreased in the sedentary simvastatin group. Moreover, the BP reduction may have contributed to improving the sensitivity of this reflex. However, additional changes in afferent pathways ([@B36]) or in the central component of this reflex should not be excluded.

Studies from our laboratory have shown an increase in cardiac vagal activity in trained mice and rats ([@B06], [@B15], [@B19]). Corroborating these data, in the present study we showed an increased vagal effect in the group subjected to both treatments (simvastatin+exercise). Other studies, however, have reported that exercise training decreased or had no effect on sympathetic activity in spontaneously hypertensive rats and in healthy and ovariectomized female rats ([@B06], [@B15], [@B23], [@B31]). Moreover, Gentlesk et al. ([@B37]) have demonstrated a reduction in cardiac death after simvastatin treatment, which was attributed to changes in sympathetic modulation. In the present study, we observed a decrease in sympathetic effect in simvastatin-treated rats.

Importantly, these beneficial changes in cardiac autonomic control observed in the simvastatin groups, trained or not, were related to reduced cardiac oxidative stress as evaluated by membrane lipoperoxidation. Exercise training ([@B14], [@B21], [@B32]) and simvastatin ([@B38]) have been reported as therapies, which improve the antioxidant mechanism and reduce oxidative stress. Corroborating these data, we observed reduced hepatic lipoperoxidation in the simvastatin-treated groups (trained or not) compared to the untreated group, but no significant changes were obtained in cardiac lipoperoxidation. Two aspects deserve a special note: first, the trained group presented about 50% reduction in hepatic lipoperoxidation compared to the sedentary group treated with simvastatin alone. This suggests an additional effect obtained by associating the therapies. Second, despite the fact that cardiac lipoperoxidation was similar in all groups studied, the correlations observed between cardiac lipoperoxidation and sympathetic and parasympathetic effects suggest that the animals presenting a decreased sympathetic effect and/or increased vagal effect also presented lower cardiac membrane lipoperoxidation. In the present study, correlation analysis (r^2^) showed that cardiac lipoperoxidation variability explained 50-60% of cardiac sympathetic or vagal effect variability. This reinforces the role of oxidative stress in cardiovascular autonomic dysfunction as previously reported by our group ([@B14], [@B32]).

Importantly, the trained females treated with simvastatin showed a marked increase in estimated physical capacity as evaluated by their response to the maximal exercise test, indicating that the training protocol used was effective. Significant correlation between oxygen consumption and maximum running velocity was reported in untrained rats ([@B17], [@B18]). Furthermore, the findings for resting bradycardia and reduced body weight are also good indications of the efficacy of the exercise training protocol in promoting overall fitness. In a recent review, Asikainen et al. ([@B13]) have shown that 9 studies on postmenopausal women have reported improvement in exercise capacity and body weight reduction after regular physical activity.

The improvement in cardiac autonomic control after short-term simvastatin treatment in an experimental model of ovarian hormone deprivation in the present study was independent of the classical plasma lipid effects of this drug, thus reinforcing the hypothesis that statin would reduce cardiovascular risk in females. These autonomic pleiotropic effects of statins may account for the patients\' outcome and should be further characterized. In this respect, compelling evidence suggests that statins have beneficial effects on survival, even for normal lipid levels ([@B08], [@B39]). However, additional studies are needed to confirm the pleiotropic effects of long-term statin treatment as well as the additional effects of associated physical training on the autonomic dysfunction and on the outcome of women in the climacterium.
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